Page last updated: 2024-11-03

riluzole and Cell Transformation, Neoplastic

riluzole has been researched along with Cell Transformation, Neoplastic in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teh, JL1
Shah, R1
La Cava, S1
Dolfi, SC1
Mehta, MS1
Kongara, S1
Price, S1
Ganesan, S1
Reuhl, KR1
Hirshfield, KM1
Karantza, V1
Chen, S2
Martino, JJ1
Wall, BA1
Mastrantoni, E1
Wilimczyk, BJ1
La Cava, SN1
Degenhardt, K1
White, E1

Other Studies

2 other studies available for riluzole and Cell Transformation, Neoplastic

ArticleYear
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
    Breast cancer research and treatment, 2015, Volume: 151, Issue:1

    Topics: Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Female; G

2015
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
    Oncogene, 2013, Sep-12, Volume: 32, Issue:37

    Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplasti

2013